Metis TechBio (HKG:7666) denied a media report alleging that China's securities regulator had issued supplemental information requests to the company, according to a Tuesday Hong Kong bourse filing.
The AI-driven nanotechnology company said the report was "factually inaccurate and misleading."
Metis TechBio said it received the China Securities Regulatory Commission's filing notice for its Hong Kong listing and H-share full circulation on March 17 and has not received any request from the regulator for supplemental information since then.